Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future Kian Fan ChungGaetano CaramoriIan M. Adcock Review Article 26 June 2009 Pages: 853 - 871
Children’s presence in research. A review of online registers C. PandolfiniM. Bonati Review Article 10 July 2009 Pages: 873 - 880
Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study Chang LiuYa-Fei ShangYi Lv Clinical Trial 21 July 2009 Pages: 881 - 885
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker L. Noehr-JensenS. T. ZwislerK. Brosen Pharmacogenetics 29 April 2009 Pages: 887 - 894
Polymorphisms and haplotype analysis of IL-4Rα Q576R and I75V in patients with penicillin allergy Chen-Zheng HuangJing YangLin-Jing Jia Pharmacogenetics 07 May 2009 Pages: 895 - 902
Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients F. LégerL. NguyenC. Puozzo Pharmacokinetics and Disposition 08 May 2009 Pages: 903 - 911
Pharmacokinetics of ritodrine diastereomers in patients pregnant with singletons and twins A. KondaT. ItoN. Inotsume Pharmacokinetics and Disposition 27 May 2009 Pages: 913 - 917
Unintended consequences of reducing QT-alert overload in a computerized physician order entry system Heleen van der SijsRavi KowlesarTeun van Gelder Pharmacoepidemiology and Prescription Open access 05 May 2009 Pages: 919 - 925
Selective prescribing of simvastatin and atorvastatin by patient characteristics at treatment initiation over a 7-year period in Finland Heli HalavaArja Helin-SalmivaaraRisto Huupponen Pharmacoepidemiology and Prescription 27 May 2009 Pages: 927 - 933
The National Poison Center in Norway: user satisfaction and a health economic evaluation Else-Lydia ToverudEva PikeLars Walløe Pharmacoeconomics 10 July 2009 Pages: 935 - 940
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET Martin BauerRudolf KarchOliver Langer Short Communication 05 August 2009 Pages: 941 - 946
CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases Melanie S. JoyKimberly Dornbrook-LavenderJoyce A. Goldstein Short Communication 11 August 2009 Pages: 947 - 953
Long-term retention rate of pramipexole in the treatment of Parkinson’s disease Tapani KeränenMervi TuhkasaariHanna Kuusisto Letter to the Editors 05 May 2009 Pages: 955 - 956
Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease Maurits E. L. ArbouwKris L. L. MovigToine C. G. Egberts Letter to the Editors Open access 03 June 2009 Pages: 957 - 957